Triazoles as γ-secretase modulators

被引:17
作者
Fischer, Christian [1 ]
Zultanski, Susan L. [1 ]
Zhou, Hua [1 ]
Methot, Joey L. [1 ]
Brown, W. Colby [1 ]
Mampreian, Dawn M. [1 ]
Schell, Adam J. [1 ]
Shah, Sanjiv [1 ]
Nuthall, Hugh [1 ]
Hughes, Bethany L. [1 ]
Smotrov, Nadja [1 ]
Kenific, Candia M. [1 ]
Cruz, Jonathan C. [1 ]
Walker, Deborah [1 ]
Bouthillette, Melanie [1 ]
Nikov, George N. [1 ]
Savage, Dan F. [1 ]
Jeliazkova-Mecheva, Valentina V. [1 ]
Diaz, Damaris [1 ]
Szewczak, Alexander A. [1 ]
Bays, Nathan [1 ]
Middleton, Richard E. [1 ]
Munoz, Benito [1 ]
Shearman, Mark S. [1 ]
机构
[1] Merck Res Labs Boston, Boston, MA 02115 USA
关键词
Alzheimer; Secretase; GSM; Abeta lowering; Lead optimization; MEDICINAL CHEMISTRY; ALZHEIMERS-DISEASE; DERIVATIVES; INHIBITORS; PRECURSOR;
D O I
10.1016/j.bmcl.2011.04.089
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Synthesis, SAR, and evaluation of aryl triazoles as novel gamma secretase modulators (GSMs) are presented in this communication. Starting from the literature and in-house leads, we evaluated a range of five-membered heterocycles as replacements for olefins commonly found in non-acid GSMs. 1,2,3-C-aryl-triazoles were identified as suitable replacements which exhibited good modulation of gamma-secretase activity, excellent pharmacokinetics and good central lowering of A beta 42 in Sprague-Dawley rats. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4083 / 4087
页数:5
相关论文
共 38 条
[1]  
[Anonymous], ALZH DIS FACTS FIG
[2]   Quantitative measurement of changes in amyloid-β(40) in the rat brain and cerebrospinal fluid following treatment with the γ-secretase inhibitor LY-411575 [N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide] [J].
Best, JD ;
Jay, MT ;
Otu, F ;
Ma, J ;
Nadin, A ;
Ellis, S ;
Lewis, HD ;
Pattison, C ;
Reilly, M ;
Harrison, T ;
Shearman, MS ;
Williamson, TL ;
Atack, JR .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (02) :902-908
[3]  
Blurton P., 2008, PCT Int. Appl., Patent No. [WO 2008099210, 2008099210]
[4]  
BREHER D, 2008, CURR TOP MED CHEM, V8, P54
[5]  
BUTCHER JW, 2002, Patent No. 200205860
[6]   Quantitation of amyloid-β peptides in biological milieu using a novel homogeneous time-resolved fluorescence (HTRF) assay [J].
Clarke, EE ;
Shearman, MS .
JOURNAL OF NEUROSCIENCE METHODS, 2000, 102 (01) :61-68
[7]   The secretases: enzymes with therapeutic potential in Alzheimer disease [J].
De Strooper, Bart ;
Vassar, Robert ;
Golde, Todd .
NATURE REVIEWS NEUROLOGY, 2010, 6 (02) :99-107
[8]   GENERATION OF BETA-A4 FROM THE AMYLOID PROTEIN-PRECURSOR AND FRAGMENTS THEREOF [J].
DYRKS, T ;
DYRKS, E ;
MONNING, U ;
URMONEIT, B ;
TURNER, J ;
BEYREUTHER, K .
FEBS LETTERS, 1993, 335 (01) :89-93
[9]  
FISCHER C, 2008, Patent No. 2008156580
[10]   Quinazolinones as γ-secretase modulators [J].
Fischer, Christian ;
Shah, Sanjiv ;
Hughes, Bethany L. ;
Nikov, George N. ;
Crispino, Jamie L. ;
Middleton, Richard E. ;
Szewczak, Alexander A. ;
Munoz, Benito ;
Shearman, Mark S. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) :773-776